ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Emre Taylan Duman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3957-9369; OpenAlex author ID A5016174245. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117649 ↗
A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. Co-author DOI 10.1093/nargab/lqae057 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Adi Danieli‐Mackay · 2 shared papers, 2024–2026 · strength 0.43
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057 ↗
Argyris Papantonis · 2 shared papers, 2024–2026 · strength 0.43
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057 ↗
Gabriela Salinas Riester · 2 shared papers, 2024–2026 · strength 0.43
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057 ↗
Tiago De Oliveira · 1 shared paper, 2026 · strength 0.22
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
Shiv K. Singh · 1 shared paper, 2026 · strength 0.22
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
Lena‐Christin Conradi · 1 shared paper, 2026 · strength 0.22
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
Lukas Klein · 1 shared paper, 2026 · strength 0.22
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
Matthias Dobbelstein · 1 shared paper, 2026 · strength 0.22
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649 ↗
Elisabeth Heßmann · 1 shared paper, 2024 · strength 0.21
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057 ↗
Volker Ellenrieder · 1 shared paper, 2024 · strength 0.21
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.